Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PFAI vs CLOV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PFAI
Pinnacle Food Group Limited Class A Common Shares

Home Improvement

Consumer CyclicalNASDAQ • CA
Market Cap$29M
5Y Perf.+17.6%
CLOV
Clover Health Investments, Corp.

Medical - Healthcare Plans

HealthcareNASDAQ • US
Market Cap$1.37B
5Y Perf.-21.2%

PFAI vs CLOV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PFAI logoPFAI
CLOV logoCLOV
IndustryHome ImprovementMedical - Healthcare Plans
Market Cap$29M$1.37B
Revenue (TTM)$3M$2.21B
Net Income (TTM)$286K$-57M
Gross Margin47.3%42.5%
Operating Margin18.7%-2.6%
Forward P/E177.3x62.6x
Total Debt$163K$0.00
Cash & Equiv.$686K$78M

PFAI vs CLOVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PFAI
CLOV
StockApr 25May 26Return
Pinnacle Food Group… (PFAI)100117.6+17.6%
Clover Health Inves… (CLOV)10078.8-21.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: PFAI vs CLOV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PFAI leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Clover Health Investments, Corp. is the stronger pick specifically for valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PFAI
Pinnacle Food Group Limited Class A Common Shares
The Income Pick

PFAI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.53
  • Rev growth 56.6%, EPS growth -63.7%
  • -6.5% 10Y total return vs CLOV's -73.7%
Best for: income & stability and growth exposure
CLOV
Clover Health Investments, Corp.
The Insurance Pick

CLOV is the clearest fit if your priority is value.

  • Lower P/E (62.6x vs 177.3x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthPFAI logoPFAI56.6% revenue growth vs CLOV's 40.3%
ValueCLOV logoCLOVLower P/E (62.6x vs 177.3x)
Quality / MarginsPFAI logoPFAI8.7% margin vs CLOV's -2.6%
Stability / SafetyPFAI logoPFAIBeta 0.53 vs CLOV's 1.22
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PFAI logoPFAI+20.6% vs CLOV's -20.0%
Efficiency (ROA)PFAI logoPFAI6.1% ROA vs CLOV's -9.6%

PFAI vs CLOV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PFAIPinnacle Food Group Limited Class A Common Shares

Segment breakdown not available.

CLOVClover Health Investments, Corp.
FY 2025
Insurance Segment
100.0%$50M

PFAI vs CLOV — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPFAILAGGINGCLOV

Income & Cash Flow (Last 12 Months)

PFAI leads this category, winning 3 of 4 comparable metrics.

CLOV is the larger business by revenue, generating $2.2B annually — 672.1x PFAI's $3M. PFAI is the more profitable business, keeping 8.7% of every revenue dollar as net income compared to CLOV's -2.6%.

MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
RevenueTrailing 12 months$3M$2.2B
EBITDAEarnings before interest/tax-$55M
Net IncomeAfter-tax profit-$57M
Free Cash FlowCash after capex$55M
Gross MarginGross profit ÷ Revenue+47.3%+42.5%
Operating MarginEBIT ÷ Revenue+18.7%-2.6%
Net MarginNet income ÷ Revenue+8.7%-2.6%
FCF MarginFCF ÷ Revenue-27.2%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year+62.0%
EPS Growth (YoY)Latest quarter vs prior year
PFAI leads this category, winning 3 of 4 comparable metrics.

Valuation Metrics

CLOV leads this category, winning 3 of 3 comparable metrics.
MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
Market CapShares × price$29M$1.4B
Enterprise ValueMkt cap + debt − cash$28M$1.3B
Trailing P/EPrice ÷ TTM EPS177.25x-15.76x
Forward P/EPrice ÷ next-FY EPS est.62.62x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple29.50x
Price / SalesMarket cap ÷ Revenue8.75x0.71x
Price / BookPrice ÷ Book value/share79.36x4.49x
Price / FCFMarket cap ÷ FCF
CLOV leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

PFAI leads this category, winning 4 of 6 comparable metrics.

PFAI delivers a 61.3% return on equity — every $100 of shareholder capital generates $61 in annual profit, vs $-17 for CLOV. On the Piotroski fundamental quality scale (0–9), PFAI scores 6/9 vs CLOV's 2/9, reflecting solid financial health.

MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
ROE (TTM)Return on equity+61.3%-17.1%
ROA (TTM)Return on assets+6.1%-9.6%
ROICReturn on invested capital-34.0%
ROCEReturn on capital employed+34.7%-24.5%
Piotroski ScoreFundamental quality 0–962
Debt / EquityFinancial leverage0.35x
Net DebtTotal debt minus cash-$523,124-$78M
Cash & Equiv.Liquid assets$685,796$78M
Total DebtShort + long-term debt$162,672$0
Interest CoverageEBIT ÷ Interest expense
PFAI leads this category, winning 4 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

PFAI leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in PFAI five years ago would be worth $9,350 today (with dividends reinvested), compared to $3,256 for CLOV. Over the past 12 months, PFAI leads with a +20.6% total return vs CLOV's -20.0%. The 3-year compound annual growth rate (CAGR) favors CLOV at 45.1% vs PFAI's -2.2% — a key indicator of consistent wealth creation.

MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
YTD ReturnYear-to-date+72.4%+11.2%
1-Year ReturnPast 12 months+20.6%-20.0%
3-Year ReturnCumulative with dividends-6.5%+205.7%
5-Year ReturnCumulative with dividends-6.5%-67.4%
10-Year ReturnCumulative with dividends-6.5%-73.7%
CAGR (3Y)Annualised 3-year return-2.2%+45.1%
PFAI leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

PFAI leads this category, winning 2 of 2 comparable metrics.

PFAI is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CLOV's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PFAI currently trades 75.9% from its 52-week high vs CLOV's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
Beta (5Y)Sensitivity to S&P 5000.53x1.22x
52-Week HighHighest price in past year$4.93$3.92
52-Week LowLowest price in past year$1.30$1.58
% of 52W HighCurrent price vs 52-week peak+75.9%+68.4%
RSI (14)Momentum oscillator 0–10057.767.0
Avg Volume (50D)Average daily shares traded7K5.6M
PFAI leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricPFAI logoPFAIPinnacle Food Gro…CLOV logoCLOVClover Health Inv…
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$3.33
# AnalystsCovering analysts9
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+4.0%
Insufficient data to determine a leader in this category.
Key Takeaway

PFAI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CLOV leads in 1 (Valuation Metrics).

Best OverallPinnacle Food Group Limited… (PFAI)Leads 4 of 6 categories
Loading custom metrics...

PFAI vs CLOV: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is PFAI or CLOV a better buy right now?

For growth investors, Pinnacle Food Group Limited Class A Common Shares (PFAI) is the stronger pick with 56.

6% revenue growth year-over-year, versus 40. 3% for Clover Health Investments, Corp. (CLOV). Pinnacle Food Group Limited Class A Common Shares (PFAI) offers the better valuation at 177. 3x trailing P/E, making it the more compelling value choice. Analysts rate Clover Health Investments, Corp. (CLOV) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — PFAI or CLOV?

Over the past 5 years, Pinnacle Food Group Limited Class A Common Shares (PFAI) delivered a total return of -6.

5%, compared to -67. 4% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: PFAI returned -6. 5% versus CLOV's -73. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — PFAI or CLOV?

By beta (market sensitivity over 5 years), Pinnacle Food Group Limited Class A Common Shares (PFAI) is the lower-risk stock at 0.

53β versus Clover Health Investments, Corp. 's 1. 22β — meaning CLOV is approximately 130% more volatile than PFAI relative to the S&P 500.

04

Which is growing faster — PFAI or CLOV?

By revenue growth (latest reported year), Pinnacle Food Group Limited Class A Common Shares (PFAI) is pulling ahead at 56.

6% versus 40. 3% for Clover Health Investments, Corp. (CLOV). On earnings-per-share growth, the picture is similar: Pinnacle Food Group Limited Class A Common Shares grew EPS -63. 7% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — PFAI or CLOV?

Pinnacle Food Group Limited Class A Common Shares (PFAI) is the more profitable company, earning 8.

7% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PFAI leads at 18. 7% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — PFAI leads at 47. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — PFAI or CLOV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is PFAI or CLOV better for a retirement portfolio?

For long-horizon retirement investors, Pinnacle Food Group Limited Class A Common Shares (PFAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

53)). Both have compounded well over 10 years (PFAI: -6. 5%, CLOV: -73. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between PFAI and CLOV?

These companies operate in different sectors (PFAI (Consumer Cyclical) and CLOV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PFAI

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 28%
  • Net Margin > 5%
Run This Screen
Stocks Like

CLOV

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 31%
  • Gross Margin > 25%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PFAI and CLOV on the metrics below

Revenue Growth>
%
(PFAI: 56.6% · CLOV: 62.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.